Tags: APFN | EU | Britain | Tate

Tate Galleries Won't Accept Donations from Sackler Family

Friday, 22 March 2019 07:38 AM EDT

LONDON (AP) — Britain's Tate group of galleries won't accept future donations from the charitable arm of a family embroiled in the U.S. opioid crisis.

The Tate says the Sackler family has given generously in the past but under "the present circumstances we do not think it right to seek or accept further donations."

Members of the Sackler family own Stamford, Connecticut-based Purdue Pharma, maker of the prescription painkiller OxyContin. Purdue has been criticized for downplaying the addictiveness of OxyContin, but the company says its products were approved by regulators and prescribed by doctors.

The statement marks the second time this week that a British museum has shunned money from the Sackler Trust. The National Portrait Gallery and the trust issued a statement Tuesday saying a 1 million-pound ($1.3 million) donation wouldn't proceed.

© Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


GlobalTalk
Britain's Tate group of galleries won't accept future donations from the charitable arm of a family embroiled in the U.S. opioid crisis.The Tate says the Sackler family has given generously in the past but under "the present circumstances we do not think it right to seek or...
APFN,EU,Britain,Tate
132
2019-38-22
Friday, 22 March 2019 07:38 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved